Barclays Initiates Coverage of Palantir Technologies at Overweight

Fintel reports that on October 9, 2026, Barclays initiated coverage of Palantir Technologies (NASDAQGS:PLTR) (LSE:0A7R) with a Overweight recommendation.

Palantir Technologies Inc., based in the United States, primarily operates within the data analysis software industry. This company specializes in big data analytics, developing software that integrates, visualizes, secures, and analyzes information. Key to its offering are two main platforms: Palantir Gotham, used by government agencies, defense, and intelligence sectors; and Palantir Foundry, serving private institutions by enabling comprehensive data environments and enhancing operational efficiencies. Notably, Palantir is also engaged in projects focusing on artificial intelligence and public health, with significant involvements in pandemic response analytics and surveillance technologies. The company has established itself as a critical tool in data-driven decision-making processes, supporting both governmental and private sector clients globally.

Prior to this coverage initiation, the stock recorded a closing price of $198.78 on October 8, 2026. This latest close of $198.78 on October 8, 2026, represents a one-week price change of +4.60% from a baseline close of $190.04 on October 1, 2026. Over a one-month period, the stock experienced a price change of +16.72% from a baseline close of $170.30 on September 8, 2026.

As of October 2, 2026, the current consensus mean target price for Palantir Technologies was $204.85, representing an implied change of +3.05% from the market price. The current consensus median target price was recorded at $211.70. This mean target reflects a consensus target revision of +0.58% from the prior consensus mean target of $203.67 recorded on September 15, 2026.

In terms of analyst sentiment, the recommendation period as of September 1, 2026, showed a total of 39 recommendations, consisting of 12 strong buy, 16 buy, 9 hold, 1 sell, and 1 strong sell ratings. This distribution represents a positive recommendation percentage of 71.8%, a hold recommendation percentage of 23.1%, and a negative recommendation percentage of 5.1%. In comparison, the prior recommendation period as of August 1, 2026, also had 39 total recommendations, with 12 strong buy, 15 buy, 10 hold, 1 sell, and 1 strong sell ratings, translating to a prior positive recommendation percentage of 69.2%, a hold percentage of 25.6%, and a negative percentage of 5.1%.

The company reported its latest earnings on August 3, 2026, with actual earnings per share (EPS) of 0.41, exceeding the estimated EPS of 0.3544, which represents an EPS surprise of +15.69%. Actual revenue was $1,935,464,000.00, compared to the estimated revenue of $1,840,805,587.00. The upcoming earnings date is scheduled for November 2, 2026.

Other recent analyst actions include Goldman Sachs upgrading the stock from Neutral to Buy on October 8, 2026. Additionally, Rosenblatt maintained a Buy rating on September 23, 2026, and UBS maintained a Buy rating on September 15, 2026. Earlier in September, both DA Davidson and Rosenblatt maintained Buy ratings on September 11, 2026.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.